HemaSphere
(Jun 2022)
PB2261: LINEZOLID AS A SAFE ANTIMICROBIAL AGENT IN THROMBOCYTOPENIC PATIENTS UNDERGOING CHEMOTHERAPY FOR HEMATOLOGIC MALIGNANCIES
- F. Angotzi,
- A. Cellini,
- S. Marinello,
- A. Cattelan,
- L. Trentin,
- C. Gurrieri,
- F. Lessi
Affiliations
- F. Angotzi
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua
- A. Cellini
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua
- S. Marinello
- 2 Infective and Tropical Disease Unit, Padua University Hospital, Padua, Italy
- A. Cattelan
- 2 Infective and Tropical Disease Unit, Padua University Hospital, Padua, Italy
- L. Trentin
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua
- C. Gurrieri
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua
- F. Lessi
- 1 Hematology and Clinical Immunology Unit, Department of Medicine, University of Padua
- DOI
-
https://doi.org/10.1097/01.HS9.0000851872.90312.73
- Journal volume & issue
-
Vol. 6
pp.
2131
– 2132
WeChat QR code